News

Two million euros for XO Life GmbH

XO Life raises over 2 million euros for the expansion of the Patient Insights platform.

PressBOX
18.10.2023

MedTech start-up XO Life, with offices in Berlin and Munich, has recently raised more than €2 million in funding to further develop its Patient Insights platform, which was originally conceived as a leading platform for reporting and providing information on side effects of medications and therapies. The expanded platform aims to provide patients with a way to record their experiences with their health, medications and conditions in a standardized and privacy-compliant way. These so-called Patient-Reported Outcomes (PROs) can then be compared with the experiences of other users and made available to the healthcare industry in anonymized form.

The company is working closely with Charité's PROMIS Institute Germany and various pharmaceutical manufacturers to make the recording of patient experience on its platform a standard in healthcare. The latest funding round was supported by various investors, including the international healthcare VC SeedLink, the corporate VC MediVentures, Aescuvest and other healthcare technology service providers. Dr. Friderike Bruchman, Co-Founder & CEO of XO Life, was positive about the collaboration with the new shareholders and emphasized that their platform will set a benchmark in the direct collection of patient insights in the real care setting and enable both patients and all healthcare stakeholders to participate.

MedWatcher

Contact

E-mail

Contact for companies:

fachkreise@xo-life.com

Press

Our press contact for inquiries:

presse@medwatcher.io

Office

We can also be reached by classical means:

XO Life Ltd.
Agnes Pockels Arc 180992 Munich

The MedWatcher is in demand.

Stay up to date.

How an innovative digital platform supports precision medicine

XO Life introduces an innovative communication platform.
Read article
World
18.10.23

How a platform makes big data usable for medicine

MedWatch supports medical research by collecting real-world evidence.
Read article
Handelsblatt
18.10.23

One night, ten pitches: These start-ups present themselves

MedWatcher presented the benefits and features at Pitch Night 2023.
Read article
en:hub
18.10.23

Position yourself and your pharmacy as a health advisor with MedWatcher

MedWatcher and "FRAG DIE APOTHEKE" connect end customers, pharmacists and the pharmaceutical industry.
Read article
TheDigitalPharmacy
18.10.23

Medwatcher: Instagram for patients

MedWatcher, the "Instagram for Patient:ins," provides a platform for reliable drug information.
Read article
Pharmacy adhoc
18.10.23

MedWatcher creates access to valuable feedback from cancer patients

MedWatcher, in cooperation with the EORTC, gives cancer patients access to standardized questionnaires.
Read article
PRESSEPortal
18.10.23

MedWatcher: Patient information for research

MedWatcher and EORTC collaborate to support cancer patients and research through real-world data.
Read article
Pharma Relations
18.10.23

Patient platform MedWatcher wants to cooperate with pharmacies

MedWatcher partners with "Ask the Pharmacy" to provide specialized health information.
Read article
German Pharmacist Newspaper
18.10.23